Tri Locum Partners LP - Q1 2023 holdings

$328 Million is the total value of Tri Locum Partners LP's 47 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 101.4% .

 Value Shares↓ Weighting
REGN NewREGENERON PHARMACEUTICALS$35,651,44043,389
+100.0%
10.86%
WST SellWEST PHARMACEUTICAL SVSC INC$23,154,590
+1.3%
66,830
-31.2%
7.05%
-23.7%
ABT NewABBOTT LABS$17,700,451174,802
+100.0%
5.39%
TNDM NewTANDEM DIABETES CARE INC$16,952,563417,448
+100.0%
5.16%
LLY SellLILLY ELI & CO$15,264,332
-23.4%
44,448
-18.4%
4.65%
-42.3%
CTLT NewCATALENT INC$14,810,968225,399
+100.0%
4.51%
ILMN NewILLUMINA INC$14,608,55862,819
+100.0%
4.45%
ARKK NewARK ETF TRunit$14,119,000350,000
+100.0%
4.30%
SRPT SellSAREPTA THERAPEUTICS INC$12,261,495
-20.9%
88,961
-25.7%
3.73%
-40.5%
AVDL BuyAVADEL PHARMACEUTICALS PLCsponsored adr$12,156,209
+148.0%
1,327,097
+93.9%
3.70%
+86.8%
MRK SellMERCK & CO INC$12,154,206
-13.7%
114,242
-10.0%
3.70%
-35.0%
AXSM SellAXSOME THERAPEUTICS INC$9,202,964
-40.4%
149,205
-25.4%
2.80%
-55.1%
TMO NewTHERMO FISHER SCIENTIFIC INC$9,157,94315,889
+100.0%
2.79%
TEVA NewTEVA PHARMACEUTICAL INDS LTDsponsored ads$8,959,5011,012,373
+100.0%
2.73%
EVH NewEVOLENT HEALTH INCcl a$8,696,957268,011
+100.0%
2.65%
XENE BuyXENON PHARMACEUTICALS INC$7,935,717
+115.6%
221,730
+137.5%
2.42%
+62.3%
ABBV NewABBVIE INC$7,843,07649,213
+100.0%
2.39%
BMRN SellBIOMARIN PHARMACEUTICAL INC$7,397,047
-42.8%
76,070
-39.1%
2.25%
-56.9%
SellSTEVANATO GROUP S P A$7,186,395
-30.3%
277,467
-51.7%
2.19%
-47.5%
RETA SellREATA PHARMACEUTICALS INCcl a$6,110,370
+13.7%
67,206
-52.5%
1.86%
-14.4%
GH BuyGUARDANT HEALTH INC$5,977,458
+68.5%
255,011
+95.5%
1.82%
+26.9%
NewVENTYX BIOSCIENCES INC$5,120,207152,842
+100.0%
1.56%
APLS SellAPELLIS PHARMACEUTICALS INC$5,082,086
-55.7%
77,048
-65.3%
1.55%
-66.6%
QURE NewUNIQURE NV$4,577,278227,273
+100.0%
1.39%
INSP NewINSPIRE MED SYS INC$4,101,60917,523
+100.0%
1.25%
SellASTRIA THERAPEUTICS INC$3,657,646
-62.3%
275,011
-57.8%
1.11%
-71.6%
AKRO SellAKERO THERAPEUTICS INC$3,386,928
-52.0%
88,524
-31.3%
1.03%
-63.9%
XFOR BuyX4 PHARMACEUTICALS INC$3,374,281
-8.3%
3,878,484
+4.6%
1.03%
-31.0%
MDGL SellMADRIGAL PHARMACEUTICALS INC$3,354,090
-56.2%
13,845
-47.5%
1.02%
-67.0%
VKTX NewVIKING THERAPEUTICS INC$3,330,000200,000
+100.0%
1.01%
BEAM BuyBEAM THERAPEUTICS INC$3,283,383
+2.3%
107,230
+30.7%
1.00%
-23.0%
PTGX NewPROTAGONIST THERAPEUTICS INC$3,069,396133,452
+100.0%
0.94%
RXDX NewPROMETHEUS BIOSCIENCES INC$3,055,40028,470
+100.0%
0.93%
ISEE SellIVERIC BIO INC$2,596,279
-50.1%
106,711
-56.1%
0.79%
-62.4%
NewROIVANT SCIENCES LTD$2,542,631344,530
+100.0%
0.77%
ETNB New89BIO INC$2,394,537157,225
+100.0%
0.73%
ALT BuyALTIMMUNE INC$2,231,595
-58.4%
528,814
+62.4%
0.68%
-68.6%
PRAX BuyPRAXIS PRECISION MEDICINES I$2,013,078
+3431.7%
2,488,354
+10205.0%
0.61%
+2565.2%
VRNA NewVERONA PHARMA PLCsponsored ads$1,964,10597,814
+100.0%
0.60%
EOLS NewEVOLUS INC$1,355,876160,269
+100.0%
0.41%
FEMY BuyFEMASYS INC$137,233
+49.2%
126,482
+23.1%
0.04%
+13.5%
AM SellANTERO MIDSTREAM CORP$116,586
-28.9%
11,114
-26.7%
0.04%
-45.5%
BTG NewB2GOLD CORP$75,15919,076
+100.0%
0.02%
PGRE NewPARAMOUNT GROUP INC$68,43615,008
+100.0%
0.02%
ETRN NewEQUITRANS MIDSTREAM CORP$58,55710,131
+100.0%
0.02%
SWN NewSOUTHWESTERN ENERGY CO$51,78510,357
+100.0%
0.02%
UNIT SellUNITI GROUP INC$40,364
-41.5%
11,370
-9.0%
0.01%
-57.1%
NLTX ExitNEOLEUKIN THERAPEUTICS INC$0-10,248
-100.0%
-0.00%
MBIO ExitMUSTANG BIO INC$0-33,318
-100.0%
-0.01%
OCX ExitONCOCYTE CORP$0-38,847
-100.0%
-0.01%
CRTX ExitQUINCE THERAPEUTICS INC$0-22,269
-100.0%
-0.01%
ExitLUMIRADX LTD$0-15,621
-100.0%
-0.01%
SYBX ExitSYNLOGIC INC$0-20,961
-100.0%
-0.01%
ExitPOLARITYTE INC$0-24,743
-100.0%
-0.01%
BYSI ExitBEYONDSPRING INC$0-10,833
-100.0%
-0.01%
OVID ExitOVID THERAPEUTICS INC$0-10,009
-100.0%
-0.01%
ExitINVIVYD INC$0-14,967
-100.0%
-0.01%
HBIO ExitHARVARD BIOSCIENCE INC$0-10,032
-100.0%
-0.01%
PASG ExitPASSAGE BIO INC$0-22,661
-100.0%
-0.01%
OMIC ExitSINGULAR GENOMICS SYSTEMS IN$0-16,215
-100.0%
-0.01%
ExitPARDES BIOSCIENCES INC$0-19,757
-100.0%
-0.01%
AMRX ExitAMNEAL PHARMACEUTICALS INC$0-21,622
-100.0%
-0.02%
ExitSOMALOGIC INC CLASS A$0-16,619
-100.0%
-0.02%
BVS ExitBIOVENTUS INC$0-16,857
-100.0%
-0.02%
ExitXERIS BIOPHARMA HOLDINGS INC$0-36,766
-100.0%
-0.02%
ORGO ExitORGANOGENESIS HLDGS INC$0-18,527
-100.0%
-0.02%
CRMD ExitCORMEDIX INC$0-13,812
-100.0%
-0.02%
EAF ExitGRAFTECH INTL LTD$0-11,869
-100.0%
-0.02%
ExitDOUGLAS ELLIMAN INC$0-15,785
-100.0%
-0.03%
TCS ExitCONTAINER STORE GROUP INC$0-15,026
-100.0%
-0.03%
LL ExitLL FLOORING HOLDINGS INC$0-13,185
-100.0%
-0.03%
GPRO ExitGOPRO INCcl a$0-16,062
-100.0%
-0.03%
LPRO ExitOPEN LENDING CORP$0-12,661
-100.0%
-0.03%
STAR ExitISTAR INC$0-11,615
-100.0%
-0.04%
MTW ExitMANITOWOC CO INC$0-10,358
-100.0%
-0.04%
SFL ExitSFL CORPORATION LTD$0-10,702
-100.0%
-0.04%
AIV ExitAPARTMENT INVT & MGMT COcl a$0-14,169
-100.0%
-0.04%
HPP ExitHUDSON PAC PPTYS INC$0-11,426
-100.0%
-0.04%
PDM ExitPIEDMONT OFFICE REALTY TR IN$0-16,088
-100.0%
-0.06%
WU ExitWESTERN UN CO$0-11,096
-100.0%
-0.06%
AHH ExitARMADA HOFFLER PPTYS INC$0-14,573
-100.0%
-0.07%
ARGX ExitARGENX SEsponsored adr$0-1,299
-100.0%
-0.20%
APLS ExitAPELLIS PHARMACEUTICALS INCcall$0-17,200
-100.0%
-0.36%
BMRN ExitBIOMARIN PHARMACEUTICAL INCcall$0-13,100
-100.0%
-0.55%
GH ExitGUARDANT HEALTH INCcall$0-62,600
-100.0%
-0.69%
PTGX ExitPROTAGONIST THERAPEUTICS INCcall$0-199,500
-100.0%
-0.88%
RXDX ExitPROMETHEUS BIOSCIENCES INCcall$0-25,700
-100.0%
-1.14%
RVNC ExitREVANCE THERAPEUTICS INCcall$0-166,300
-100.0%
-1.24%
KZR ExitKEZAR LIFE SCIENCES INC$0-473,544
-100.0%
-1.35%
TGTX ExitTG THERAPEUTICS INC$0-288,462
-100.0%
-1.38%
SAVA ExitCASSAVA SCIENCES INCcall$0-127,200
-100.0%
-1.52%
INMD ExitINMODE LTD$0-127,242
-100.0%
-1.84%
MRTX ExitMIRATI THERAPEUTICS INC$0-104,598
-100.0%
-1.92%
NVCR ExitNOVOCURE LTDcall$0-72,400
-100.0%
-2.15%
PCVX ExitVAXCYTE INC$0-113,477
-100.0%
-2.20%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-176,109
-100.0%
-3.18%
ASND ExitASCENDIS PHARMA A/Ssponsored adr$0-99,215
-100.0%
-4.90%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FEMASYS INC10Q3 20230.5%
REGENERON PHARMACEUTICALS9Q3 202313.8%
LILLY ELI & CO9Q2 20239.5%
X4 PHARMACEUTICALS INC8Q3 20233.0%
XENON PHARMACEUTICALS INC8Q3 20232.4%
ARGENX SE7Q3 202312.8%
STEVANATO GROUP S P A7Q2 20235.8%
PROTAGONIST THERAPEUTICS INC7Q2 20237.1%
AVADEL PHARMACEUTICALS PLC7Q3 20236.4%
BELLUS HEALTH INC NEW7Q3 20224.3%

View Tri Locum Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-27
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16

View Tri Locum Partners LP's complete filings history.

Compare quarters

Export Tri Locum Partners LP's holdings